Rabipur
Sponsors
Leids Universitair Medisch Centrum (LUMC), Institute Of Tropical Medicine, GlaxoSmithKline, CureVac, U.S. Army Medical Research and Development Command
Conditions
MalariaRabiesVirus Diseaseshealth volunteerstrabies pre-exposure prophylaxis
Phase 1
Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults
CompletedNCT02238756
Start: 2014-09-30End: 2016-11-30Target: 72Updated: 2018-06-06
Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01B
CompletedNCT02458092
Start: 2008-04-30End: 2009-06-30Updated: 2023-06-28
Phase 2
Phase 3
A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.
CompletedNCT02545517
Start: 2015-10-05End: 2022-12-23Updated: 2024-07-18
An open-label pilot study to assess pain experience and usability of different injection techniques and devices for the administration of the purified chick-embryo cell-culture rabies vaccine in children aged 4 to 14 years
RecruitingCTIS2024-515122-89-00
Start: 2025-01-08Target: 48Updated: 2025-08-13
(Pre-BCGvacc) BCG vaccination: can pre-vaccination immune status predict outcome?
RecruitingCTIS2024-514428-18-00
Start: 2025-10-24Target: 50Updated: 2025-12-12